Canopy Growth Corp (NASDAQ:CGC) Share Price

Company Profile

Business description
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Contact
1 Hershey Drive
Smiths FallsONK7A 0A8
CAN
T: +1 855 558-9333
https://www.canopygrowth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,128

Recommended

Companies with US exposure are better positioned to benefit from easing prohibition, writes Kristoffer Inton.

Kristoffer Inton | 26 October 2020

Morningstar thinks these companies are well positioned to benefit from one of five key trends during the next decade, writes Susan Dziubinski.

Susan Dziubinski | 01 October 2020

In ten years’ time, you won’t be illegally smoking cannabis, you’ll be legally eating it. Here are some stocks to watch.

Lex Hall | 22 September 2020

Index	Last price	Change	% Change
All Ordinaries	8,964.20	1.20	-0.01%
CAC 40	8,358.34	73.27	-0.87%
DAX 40	24,677.93	316.90	-1.27%
Dow JONES (US)	51,920.62	71.72	0.14%
FTSE 100	10,439.75	90.14	-0.86%
HKSE	22,671.86	405.05	-1.76%
NASDAQ	25,358.60	118.03	-0.46%
Nikkei 225	69,360.88	3,005.46	-4.15%
NZX 50 Index	13,495.24	2.19	0.02%
S&P 500	7,357.49	0.73	-0.01%
S&P/ASX 200	8,764.20	0.20	0.00%
SSE Composite Index	4,027.26	93.02	-2.26%